ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors
15 juin 2020 07h30 HE
|
ContraFect Corporation
YONKERS, N.Y., June 15, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Kraig Biocraft Laboratories files Application for Up-listing to the Nasdaq Capital Market
09 juin 2020 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., June 09, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), a leading developer of spider silk based fibers, announces that it has submitted its...
ContraFect Reports First Quarter 2020 Financial Results and Provides Business Update
15 mai 2020 07h30 HE
|
ContraFect Corporation
YONKERS, N.Y., May 15, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Kraig Biocraft Laboratories Prepares for 2020 Production
12 mai 2020 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., May 12, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”) announces that Company is preparing to transfer production back to Prodigy...
Kraig Biocraft Laboratories Hosts Online Press Conference Today
16 avr. 2020 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces the Company will an...
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma
09 févr. 2016 11h58 HE
|
Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORD, United Kingdom, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today...
A.G. Lafley, CEO of P&G, to Reveal his Secret to Game-Changing Innovation
11 févr. 2008 08h45 HE
|
Institute for International Research
BOSTON, MA--(Marketwire - February 11, 2008) - A.G. Lafley, Chairman of the Board & CEO of
P&G, will discuss The Art and Science of Game-Changing Innovation in front
of hundreds of leading...